As MIT suggests, Almost every bed in a hospital has a manual resuscitator (Ambu-Bag) nearby, available in the event of a rapid response or code where healthcare workers maintain oxygenation by squeezing the bag. Automating this appears to be the simplest strategy that satisfies the need for low-cost mechanical ventilation, with the ability to be Read More…
Author: kairosfocus
A Caribbean-based Christian thinker with a background in physics and a focus on strategic thinking towards truly sustainable development.
Hydroxychloroquine wars, 6: Dr Zelenko’s interview with Rudy Giuliani
Here: Let us listen. END
Hydroxychloroquine wars, 5: The China tests (and report, Feb. 18)–U/D: FDA Emergency Use Authorisation announced . . .
Now that France has approved Hydroxychloroquine after Prof Raoult’s second test, it is helpful to go back and roll the tape. We need to understand why we are where we are now, over a month after China — which, unsurprisingly, did a lot of the early work on Covid-19 that we are all relying on Read More…
BREAKING: After Prof Raoult’s 78 of 80 success ratio test, France approves [Hydroxy?]Chloroquine for Covid-19
France 24, English has the vid: This is a breakthrough of hope for those who may fall victim to the disease. HT, Vivid. I link the Daily Wire report Vivid links, given the onward confirmation: France Officially Sanctions Drug After 78 Of 80 Patients Recover From COVID-19 Within Five Days By Amanda PrestigiacomoDailyWire.com The French Read More…
Tracking the Covid-19 pandemic — Our World in Data
Here is a log-lin on cases, relative to 100 as marking breakout: Likewise, for deaths, starting at the fifth: Here, we see onward unfolding of the pandemic. The 2 – 3 day doubling band is still there [and the USA is growing fastest now], but now we see where the plague is beginning to slow Read More…
Hydroxychloroquine wars, 4: Didier Raoult strikes again, with 80-patient test
BREAKING: Professor Raoult has released a further result. Using Google Translate on two tweets: Our two articles published this evening help to demonstrate: 1. The effectiveness of our protocol, on 80 patients. 2. The relevance of the association of hydroxychloroquine and azithromycin, thanks to research carried out in our P3 containment laboratory. https://t.co/Y91bsFOgB2 Read More…
An ER Doctor in NO suggests a clinical pattern for covid-19
Here we go: I am an ER MD in New Orleans. Class of 98. Every one of my colleagues have now seen several hundred Covid 19 patients and this is what I think I know. Clinical course is predictable. 2-11 days after exposure (day 5 on average) flu like symptoms start. Common are fever, headache, Read More…
Hydrochloroquine wars, 3: Belgium and Bahrain weigh in as UK PM Johnson tests positive and Dr Zelenko’s video vanishes
Fresh developments, even as in a now all too familiar development, a politically incorrect video vanishes from YouTube. The Boris Johnson case shows just how contagious this virus is, as he joins a list of leading politicians and members of their families. We definitely need a good treatment and we need it fast. In that Read More…
Hydrochloroquine wars, 2: a NY physician speaks of “hundreds” of successful patients, a Governor bans use in Nevada
First, Dr Vladimir Zelenko speaks: While, the Governor blocks: Sisolak signed an emergency order earlier Tuesday barring the use of anti-malaria drugs for someone who has the coronavirus. But Sisolak’s order does not apply to patients who are hospitalized with coronavirus. The order restricting chloroquine and hydroxychloroquine came after President Donald Trump touted the medication Read More…
A 101 video on Covid-19
Here: Food for thought. END
BREAKING: Is the 1934 Bayer anti-malarial, Chloroquine, a potential Covid-19 breakthrough treatment?
And, why is that (which was announced yesterday by Mr Trump) not top- of- fold headline news everywhere? Bayer, US, has announced, March 19: >>Bayer today announced it is joining the U.S. Government’s fight against COVID-19 with a donation of 3 million tablets of the drug Resochin (chloroquine phosphate). Resochin, a product discovered by Bayer Read More…
SIR — “Simple” Basics of Epidemics
Here is a simple SIR model — Susceptible- Infected- Removed: Here, “removed” can be by recovery or death. Obviously parameters are not exact so the next level would explore randomised changes in possible values and time varying models; noting particular clusters that give dramatic outcomes. The S(t) line is an inverted cumulative case curve — Read More…
A note on the value and validity of investors
Thirty years after Communism collapsed in ignominy, it is again fashionable to bash capitalism and the investor classes. The tone of that rhetoric is sufficiently scapegoating to justify a pause here at UD to make a few notes on a case in point. Accordingly, from the “Further” thread: KF, 232: >>the following are further interesting Read More…
Betelgeuse, black-/cavity- body radiation and star spectra
As we have seen in recent days, Betelgeuse (usually the 11th brightest visible star) has started to climb back up the magnitude scale; right on time for a 420 – 430 day cycle. That suggests that the event since October is likely a superposition of dimming cycles. The long- expected Type II supernova is put Read More…
Betelgeuse begins to re-brighten
. . . and that, at about the suggested time for an up-turn. Astronomy telegram clip: >>The Fall and Rise in Brightness of Betelgeuse ATel #13512; Edward Guinan, Richard Wasatonic (Villanova University),Thomas Calderwood (AAVSO) and Donald Carona (Texas A& M University) on 22 Feb 2020; 12:59 UTCredential Certification: Edward Guinan (edward.guinan@villanova.edu) As previously reported (see Read More…